Wednesday, June 10, 2026

Drug profile · INN

alglucosidase

alglucosidase is a starch hydrolytic enzyme.

NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — alglucosidase
Class
Route
Patents
0
Programs
3
Data quality
0.70

Quick answer

alglucosidase is a starch hydrolytic enzyme.

Key facts

INN alglucosidase
Mechanism Starch hydrolytic enzyme
Target Starch

Mechanism of action

Starch hydrolytic enzyme

Primary target: Starch

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. EFC14462 Phase 3 · Sanofi-Aventis U.S · Glycogen storage disease type II
  2. alglucosidase alfa Approved · Sanofi Pasteur MSD · Pompe Disease (Infantile-Onset)
  3. alglucosidase alfa Approved · Sanofi Pasteur MSD · Pompe Disease

Related & competitor drugs

  1. alglucosidase alfa Alimentary tract and metabolism (A16)

Frequently asked questions

What is alglucosidase?

alglucosidase is a starch hydrolytic enzyme.